P430: MOLECULAR CHARACTERIZATION OF CLINICAL RESPONSE IN NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE

• S. de Botton,
• S. Choe,
• D. Marchione,
• P. Montesinos,
• C. Recher,
• S. Vives Polo,
• E. Zarzycka,
• J. Wang,
• G. Bertani,
• M. Heuser,
• R. Calado,
• A. Schuh,
• S.-P. Yeh,
• J. Hui,
• S. Pandya,
• D. Gianolio,
• S. Daigle,
• C. DiNardo,
• H. Dohner

Affiliations

S. de Botton

1 Institut Gustave Roussy, Villejuif, France

S. Choe

2 Servier Pharmaceuticals LLC, Boston, United States of America

D. Marchione

2 Servier Pharmaceuticals LLC, Boston, United States of America

P. Montesinos

3 Hospital Universitari i Politècnic La Fe, València, Spain

C. Recher

4 Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France

S. Vives Polo

5 Hospital Universitario Germans Trias i Pujol-ICO Badalona, Josep Carreras Research Institute, Badalona, Spain

E. Zarzycka

6 Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland

J. Wang

7 Institute of Hematology & Hospital of Blood Disease, Tianjin, China

G. Bertani

8 ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

M. Heuser

9 Hannover Medical School, Hannover, Germany

R. Calado

10 Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil

A. Schuh

11 Princess Margaret Cancer Centre, Toronto, Canada

S.-P. Yeh

12 China Medical University, Taichung, Taiwan

J. Hui

2 Servier Pharmaceuticals LLC, Boston, United States of America

S. Pandya

2 Servier Pharmaceuticals LLC, Boston, United States of America

D. Gianolio

2 Servier Pharmaceuticals LLC, Boston, United States of America

S. Daigle

2 Servier Pharmaceuticals LLC, Boston, United States of America

C. DiNardo

13 The University of Texas M.D. Anderson Cancer Center, Houston, United States of America

H. Dohner

14 Ulm University Hospital, Ulm, Germany